Weighted average shares of common stock outstanding used in the calculation of basic and diluted earnings per share were as follows:


	Three Months Ended July 31,
	2026	2025
Weighted average shares outstanding-basic	8,329,512	8,274,054
Dilutive options and restricted stock	—	—

Weighted average shares outstanding-diluted	8,329,512	8,274,054

Antidilutive securities not included:
Options	854,844	628,934
Warrants	937,487	—
Restricted stock	297,669	6,250

For the three months ended July 31, 2026 and 2025, the Company reported a net loss. As a result, all potentially dilutive securities, including 70,495 and 175,773 weighted-average incremental shares, respectively, determined under the treasury stock method, were excluded from the computation of diluted loss per share because their effect would have been antidilutive, and diluted loss per share equals basic loss per share. The potentially dilutive securities excluded are contained within the antidilutive securities presented in the table above.